HighLife
develops heart valve replacement systems for the treatment of mitral regurgitation... Read moreHighLife
develops heart valve replacement systems for the treatment of mitral regurgitation... Read more
News
Jan 27, 2026
Medical Device Network
HighLife: HighLife TMVR system secures CE mark approval for MR treatment
Jun 03, 2024
GlobalNewswire
Press Release: HighLife : HighLife Receives IDE Approval to Initiate US Pivotal Clinical Study for treatment of Mitral Regurgitation
Sep 07, 2023
Medical Product Outsourcing
HighLife: HighLife Releases Large Annulus Valve for Mitral Regurgitation
Dec 21, 2020
BioSpace
HighLife SAS: Peijia Medical and HighLife Enter Into License and Technology Transfer Agreement for Transeptal Mitral Valve Replacement in Greater China
Jan 18, 2019
EU-Startups
HighLife: Paris-based HighLife raises €32 million Series B for its device to treat heart disease
Jan 18, 2019
FinSMEs
HighLife: HighLife Closes €32M Series B Financing Round
Jan 17, 2019
MassDevice
HighLife: HighLife raises $36m Series B for mitral valve replacement
May 09, 2018
BioPortfolio
HighLife: HighLife Appoints Dr. Martin Rothman as Independent Member of the Board
Jan 10, 2018
Medical Product Outsourcing
HighLife: HighLife SAS Appoints Board Chairman
Oct 30, 2017
FierceBiotech
HighLife: Sofinnova leads ex-CoreValve team to $14M round for TMVR R&D
HighLife Competitors
1
2
3
4
5
6
7
8
9
10